Fetal Monitoring, Diagnostics and Predictive Tests

Report Code: HLC089C

Publish Date: Apr 2023

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for fetal monitoring, diagnostics and predictive tests is estimated to increase from $10.4 billion in 2022 to reach $13.6 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

Report Includes

  • 17 data tables and 54 additional tables
  • Detailed overview and an up-to-date analysis of the global market for fetal monitoring, prenatal diagnostics, and predictive tests
  • Analyses of the global market trends, with historic market revenue for 2019-2021, 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential for fetal monitoring products, diagnostic and predictive tests, along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the industry
  • Estimation of the actual market size and revenue forecast for fetal monitoring and related markets in USD million values, and its corresponding market share analysis based on the product type, sample type, test type, end user, and region
  • A comparative study of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers
  • Updated information on the key mergers and acquisition deals, agreements, collaborations and other impactful strategies adopted by key players in the global market for fetal monitoring products, diagnostic and predictive tests
  • Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues
  • Descriptive company profiles of the leading global players, including Abbott Laboratories, Abcam plc, Ansh Labs LLC, Beckman Coulter Inc., Contect Medical Systems Co. Ltd., and Dragerwerk AG & Co. KGaA

Report Scope

This report aims to provide a comprehensive study of the global market for fetal monitoring, diagnostics, and predictive tests, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding fetal monitoring, diagnostics, and predictive tests.

An in-depth analysis of the global fetal monitoring, diagnostics and predictive tests market includes historical data and market projections on sales by application, product type, and end user. It describes the different types of fetal monitoring, diagnostics and predictive tests and their current and historical market revenues. This report also categorizes the global fetal monitoring, diagnostics and predictive tests market based on the region (North America, Europe, and Rest of the World).

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $10.1 billion
Market size forecast $13.6 billion
Growth rate CAGR of 5.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered type and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Countries covered United States, Canada, France, Germany, Italy, United Kingdom, Spain, Russia, China, Japan, India, South Korea, Australia, Singapore, Latin America, Middle East and Africa
Companies studied
ABBOTTABCAM PLC
AMBISEA TECHNOLOGY CORP. LTD.ANSH LABS LLC.
ATOM MEDICAL CORP.AVIVA SYSTEMS BIOLOGY LLC.
BECKMAN COULTER (SUBSIDIARY OF DANAHER CORP.)BERRY GENOMICS
BIONET AMERICA INC.BISTOS Co. LTD.
CONTEC MEDICAL SYSTEMS CO. LTD.COOPERSURGICAL INC.
CREATIVE DIAGNOSTICSDIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.
DEMEDITEC DIAGNOSTICS GMBHDRAGERWERK AG & CO. KGAA
DRE INC.DRG INTERNATIONAL INC.
EAGLE BIOSCIENCES INC.EDAN INSTRUMENTS INC.
ESAOTE SPAFUKUDA DENSHI CO. LTD.
GE HEALTHCAREGENERAL MEDITECH INC.
HITACHI HEALTHCARE AMERICASHOLOGIC INC.
HUNTLEIGH HEALTHCARE LLC.ILLUMINA INC.
INFINIUM MEDICALINSTITUTE OF ISOTOPES CO. LTD.
LEINCO TECHNOLOGIESLIFEWAVE BIOMEDICAL INC.
LUTECH INDUSTRIES INC.M&B ELECTRONIC INSTRUMENTS CO. LTD.
MEDGYN PRODUCTS INC.MEDIANA CO. LTD.
MEDICAL ECONET GMBHMEDICHECKS LTD.
MINDCHILD MEDICAL INC.MINDRAY MEDICAL INTERNATIONAL LTD.
MONOBIND INC.MYRIAD GENETICS INC.
NATERA INC.NATUS MEDICAL INC.
NEMO HEALTHCARE BVNEOVENTA MEDICAL AB
NIHON KOHDEN CORP.NONIN MEDICAL INC.
OB TOOLS LTD.PENLON LTD.
PERKINELMER INC.PHOENIX PHARMACEUTICALS INC.
RAVGENPREMAITHA HEALTH
QUEST DIAGNOSTICS INC.RAYBIOTECH INC.
RESPIRONICS INC. (PHILIPS)SEQUENOM INC.
SHENZHEN AEON TECHNOLOGY CO. LTD.SHENZHEN COMEN MEDICAL INSTRUMENTS CO. LTD.
SHENZHEN JUMPER MEDICAL EQUIPMENT CO. LTD.SIEMENS HEALTHINEERS AG
SINOHERO BIOMEDICAL ELECTRONICS CO. LTD.SMITHS MEDICAL INC.
SPACELABS HEALTHCARECANON MEDICAL SYSTEMS CORP.
USCN LIFE SCIENCES INC.ULTRASOUND TECHNOLOGIES LTD.
UNITED BIORESEARCH INC.UTAH MEDICAL PRODUCTS INC.
VCOMIN TECHNOLOGY LTD.WELCH ALLYN INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The fetal monitoring, diagnostics and predictive tests market is projected to grow from $10.0 million in 2021 to $13.6 billion in 2027, at a compound annual growth rate (CAGR) of 5.6 % during the forecast period.
Key drivers of fetal monitoring, diagnostics and predictive tests market are expanding collaborations and strategic partnerships among academia and private players; continued investment by venture capitalists and pharma companies; and active support from the FDA.
The fetal monitoring, diagnostics and predictive tests market is segmented on the basis of applications,end user, and region.
Prenatal diagnostics segment will dominate the market by the end of 2027.
Key companies in the market includes
  • GE Healthcare
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Beckman Coulter Inc.
  • Esaote SpA

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Fetal Monitoring, Diagnostics and Predictive Tests235Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights7Free
Chapter- 3: Market and Technology Background45Free
Chapter- 4: Emerging/Upcoming Technologies in the Market3Free
Chapter- 5: Regulatory Structure8Free
Chapter- 6: Market Breakdown by Application55Free
Chapter- 7: Impact of COVID-19 on the Market1Free
Chapter- 8: Competitive Landscape6Free
Chapter- 9: Company Profiles104Free
Published - Jan-2015| Analyst - Natana Raj| Code - HLC089B

Report Highlights

The global market for fetal monitoring, prenatal diagnostics, predictive tests and neonatal monitoring was valued at roughly $8.6 billion in 2013 and about $9.0 billion in 2014. This market is expected to reach about $10.9 billion by 2019, with a compound annual growth rate (CAGR) of 4.0% from 2014 to 2019.

Report Includes

  • An overview of the global markets for fetal monitoring, diagnostics, and predictive tests.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Information on the strengths and weaknesses of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers.
  • Discussion covering acquisitions, mergers, and alliances by companies and global organizations.
  • Comprehensive company profiles of major players in the industry.

Published - Apr-2011| Analyst - Shalini Shahani Dewan| Code - HLC089A

Report Highlights

The global market for fetal monitoring, diagnostics, and predictive tests reached approximately $6.2 billion in 2010.  The market is expected to rise at a compound annual growth rate (CAGR) of 4.4% and reach approximately $8 billion by 2016.

Related Reports

Global Prenatal Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS103A

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Patient Monitoring Devices: Global Markets

Published - Aug 2022 | Publisher - BCC Publishing | Code - HLC038G

The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.

Global Fetal and Neonatal Monitoring Devices Market

Published - Nov 2020 | Publisher - BCC Publishing | Code - MDS018A

The global market for fetal and neonatal monitors should grow from $4.8 billion in 2020 to $6.4 billion by 2025, at a compound annual growth rate (CAGR) of 6.1% for the period of 2020-2025.

Next Generation Sequencing for Non-invasive Prenatal Testing: Global Insights

Published - Sep 2018 | Publisher - BCC Publishing | Code - BIO173A

The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.

Recent Reports

Elder Care Services and Assistive Devices: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC062E

The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.

Direct-to-Consumer Testing Industry: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC269B

The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Health and Medical Insurance Providers: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC212B

The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.

Prefilled Syringes: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC223B

The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Water Filtration: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - MST080B

The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Fetal Monitoring, Diagnostics and Predictive Tests
Sample Report